le H0 3
. dmm Viﬂfmﬁw/ Md Am Vim/3
PM .5 71,-WNWW WM 650, 2

c egg W C So 4 i 1
4/4” ma APPROVED

 

 

nical Case Report
(For Collection of Cancerous Tissue)

UUID:2481FA5C-7D84-4CE5-BOB4-2358ECE73C1e6d
TCGA- cs- A1HO- o1A- PR dacted _
I TumorSlte

III|||||||H||lIIIHIIIIIIIIII|||||||l|||||l||ll||llllllllllelllllllll
IIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIII IIIIIIIIIII
IIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIII informed “mend

 

 

 

I personally informed this patient that a cpecimemsi would be collected to be used for research

purposes. I reviewed the
FORM with the patient and answered any questions the patient had. The patient then signed the

consent form as a free and voluntary act. A copy of this informed consent document will be retained at
our institution.

_.-,

_ ,_____—_———-——-__,

Name of Physician or'Study Coordinator Signature I Date

 

[Clinical Information]

 

Date of Blrtjuan/dd/ww)

II! Single
Gender El
El Male emaie

Cl Widow ' ”Blood Pressure Heart Rate

 

 

    

.., tW'STORwon PRESENT ILLNESS“ «3.,
ChiefComplaInts. A W W, W M)” Wakl-J ymmZE/K

Symptoms:

ClinicalFindings: #WW Woo]; $0096 W do; % Wags/F].

onnance Scale Karnofs Score -
Perf ( ky ) El 60-70 Symptomatic, in bed less than 50% of day

0 100 Asymptomatic 0-90 Symptomatic but Fully Ambulatory _
E3 40-50 Syﬁtomatic,’ in bed more than 50% of day but not bed ridden El 20-30 Bed Ridden

 

 

 

 

 

 

 

 

5% (SURREN’BMED - ‘ TIONSié-In -. g " '. ?
Route

 

» ' PAST MEDICAL HISTORY
Disorder

Date

Treatment

 

 

    

 

 

 

 

 

 

 

 

 

Menopausal Status Date of First Menses # of Pregnancies
7D Pre-menopausal ' $06M IPA 0 2,
El Peri-Menopausal Date of Last Mensa ' # of Live Births
D Post-menopausal 09 2
Birth Control: Cl Condom ml Contraceptive I:I IUD Cl Hormone Replacement
D Other: Therapy:

 

 

Current Status
Cl YES

TYPE
Cl YES NO
Current Status
:1 YES NO

Relative

Test
HIV D Positive:
B D Positive:

C D Positive:

AF P D Cl Positive:
Other:

I: Negative CI Positive:

BIT Cell Markers:

Hazards:

Alcohol

Negative

5:51;} '9

Duration

Duration

Duration

D Positive:
C] Positive:
D Positive:
D Positive:

[:1 Positive:

 

 

 

Ultrasound
x-
CT

MRI
B'

DIAGNOSTICSTUDIES'f-Hitza " _
Results

D GN
Clinical

Location of Involved L Location of

Clinical

T N

M Stage:

 

ﬁeatment Information]

Procedure
\

Tumor
Detailed Location

Extension

L Nodes
Location of L Nodes

Palpable, Non—Dissected Lymph Nodes

Dissected Lymph Nodes

its“; - ;

Distant Metastasis

Detailed Location

Distant Metastasis

Date of

 

.' =1’.‘:,' 7%? vi“? ‘ . ‘- A I..' 5""
,2 1:" ~1qu ‘4‘, :« .l a H

Date of Procedure

 

 

Pathology Form

 

ISpecimen Information!

 

 

 

   

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 
 
 

 

 

 

 

 

 

 

 

 

 

 

 

 

Collected by: __ , a 4- ,, __ Date:/_ ‘ _
Preserved by: Date: me:_
em aaSPECIMENTYPE(#fiofsamples‘prowded)w3 I ”i «r
Frozen Parafﬁn Block BloodlSerum/Plasme Slide
Diseased Normal Diseased Normal Diseased Normal Diseased Normal
2, 4,: 2
Time to LNZ Time to Formalin Time to LN2
min min min
éiéiiﬁBJATHOLOGICA-ﬂDESCRIPTIOM?! gait-Iii}?- 25*:- :;:: e a,“
Primary Tumor
Om Size Extenslon of Tumor Distance to NAT
r L h? x (—x cm ' " era-4’ " ’ cm ‘
y I
/ Lymph Nodes /
Location # Examined # Metastasized
Distant Metastasis
Organ Detailed Location Size

 

 

 

 

 

 

PatholchCal StasﬂnL
pT g N 3 M O Stage: UL:

"at”: Z CWMZJ Wﬁ¢ﬂa¢4€ (/4/ ,‘ﬂ/2)//3/U/W
( W/ 0/114” 1/2. :. ﬂag/ﬁve) H
/ Dike W/wlgwl ”ﬁve/Me : x0 / ”6742/2222

 

 

 

 

 

 

 

Mi “"9" Appellant:

I.
CELL DISTRIBUTION

Clustering

2. Cellular
1» .

cell
CC" Ce"

5mm

Gm Plum Cell

Speciﬁed: ’7 L7 )7J2DW

2. Cellular Di evaluation:
Well Moderately

 

 

 

 

Pgor
V

 

 

 

 

3. Nuclear

 

Nuclear Grade

Histological Diagnosis: I 'AfoW/zwv. WA/w/ WWW M1 6‘ 3

/
Comments: 41, U : ‘a/QQNW Wide (‘ 7261/ ”7% 411/

( iﬁtmmm nmnrornmms or com

